Please login to the form below

Video: Drive payer submission readiness for your Phase 2 and 3 products

Transform your market access processes with the PRMA Healthcheck®  late module. The digital application encourages collaboration with integrated decision-making between affiliate and global functions to build an evidence generation plan. Efficiency is increased through the systematic assessment of payer evidence readiness for your product against actual submission template requirements with a visual heatmap. An organizational vision and action plan to anticipate and mitigate value challenges to optimize payer readiness.


Understanding and adapting to evolving payer requirements is becoming increasingly important to managing market access risk and delivering commercial success. Rapid developments in the treatment landscape present new challenges for payers who have different perspectives on value and approaches to market access, while manufacturers are under pressure to bring products to market quickly. That is why we have developed the PRMA Healthcheck®  late module digital application. 

PRMA Healthcheck® late module

  • Provides a robust situational analysis based on a consistent and systemized framework that rates your current evidence generation activities against the individual requirements from payer submission templates relevant to your asset
  • Presents a comprehensive summary of the evidence gaps with a red-amber-green rating of potential challenges, encouraging early clear and consistent communication across the organization
  • Accelerates HTA submission readiness by producing a high-quality evidence generation plan driven by informed, collaborative, and integrated decision-making
  • Identifies clear responsibilities across global, regional and affiliates for implementation, recognizing that not all gaps can or will be bridged

Visit our website to learn more:

26th September 2018



Company Details

PRMA Consulting Ltd

+44 (0)1252 786284

Contact Website

Linea House
Harvest Crescent
Ancells Business Park
GU51 2UZ
United Kingdom

Latest content on this profile

The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment
Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access.
PRMA Consulting Ltd
Four recommendations to kick-start the digital transformation of your market access processes
Darren McBride shares his experience of digital transformation in pharmaceutical and biotechnology market access, and makes four recommendations for those who are keen to drive change.
PRMA Consulting Ltd
Five new case studies describe how top-10 manufacturers have transformed their market access processes

PRMA Consulting Ltd
Transforming the market access landscape with digital applications
Pharmaceutical and biotechnology companies are turning to technology more frequently to solve business issues, and are increasingly using digital technology to optimize market access for their products.Read the article >> new article helps you to:appreciate why digital applications are transforming the value and access functionsunderstand how new technology is informing direction and becoming an essential enabler in realizing visiongain insight into considerations for re-evaluating your technology and your suppliers.
PRMA Consulting Ltd
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy.
PRMA Consulting Ltd
Achieve up to 80% auto-population of your first draft HTA submission

PRMA Consulting Ltd